Ryuta Kishii

893 total citations
17 papers, 611 citations indexed

About

Ryuta Kishii is a scholar working on Molecular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Ryuta Kishii has authored 17 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Medicine, 10 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in Ryuta Kishii's work include Antibiotic Resistance in Bacteria (13 papers), Cancer therapeutics and mechanisms (9 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). Ryuta Kishii is often cited by papers focused on Antibiotic Resistance in Bacteria (13 papers), Cancer therapeutics and mechanisms (9 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). Ryuta Kishii collaborates with scholars based in United States, Japan and China. Ryuta Kishii's co-authors include Masaya Takei, Hideyuki Fukuda, M. Hosaka, Yasumichi Fukuda, Sheo B. Singh, Yuko Yamaguchi, Jun Lu, Sangita B. Patel, S.M. Soisson and Nandini Sharma and has published in prestigious journals such as Journal of Biological Chemistry, Antimicrobial Agents and Chemotherapy and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Ryuta Kishii

17 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryuta Kishii United States 13 267 236 224 132 98 17 611
Masaya Takei Japan 15 346 1.3× 246 1.0× 264 1.2× 145 1.1× 162 1.7× 22 772
Marina Y. Fosso United States 16 347 1.3× 87 0.4× 143 0.6× 227 1.7× 91 0.9× 24 791
Hideyuki Fukuda Japan 17 451 1.7× 585 2.5× 526 2.3× 100 0.8× 305 3.1× 32 1.1k
Timothy R. Kane Canada 5 287 1.1× 255 1.1× 165 0.7× 88 0.7× 81 0.8× 5 797
Raymond T. Testa United States 15 242 0.9× 453 1.9× 432 1.9× 137 1.0× 131 1.3× 25 801
Steven M. Kwasny United States 10 330 1.2× 312 1.3× 120 0.5× 144 1.1× 73 0.7× 17 685
Martin S. Linsell United States 11 254 1.0× 218 0.9× 193 0.9× 166 1.3× 82 0.8× 11 594
Takashi Fukuoka Japan 14 203 0.8× 95 0.4× 156 0.7× 113 0.9× 227 2.3× 26 638
Frédéric Collin United Kingdom 7 475 1.8× 147 0.6× 98 0.4× 186 1.4× 44 0.4× 9 705
Srinivas Kodali United States 9 271 1.0× 81 0.3× 206 0.9× 162 1.2× 95 1.0× 12 618

Countries citing papers authored by Ryuta Kishii

Since Specialization
Citations

This map shows the geographic impact of Ryuta Kishii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuta Kishii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuta Kishii more than expected).

Fields of papers citing papers by Ryuta Kishii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuta Kishii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuta Kishii. The network helps show where Ryuta Kishii may publish in the future.

Co-authorship network of co-authors of Ryuta Kishii

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuta Kishii. A scholar is included among the top collaborators of Ryuta Kishii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuta Kishii. Ryuta Kishii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Singh, Sheo B., Christopher M. Tan, David E. Kaelin, et al.. (2022). Structure activity relationship of N-1 substituted 1,5-naphthyrid-2-one analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-9). Bioorganic & Medicinal Chemistry Letters. 75. 128808–128808. 3 indexed citations
2.
Kishii, Ryuta, Yuko Yamaguchi, & Masaya Takei. (2017). In Vitro Activities and Spectrum of the Novel Fluoroquinolone Lascufloxacin (KRP-AM1977). Antimicrobial Agents and Chemotherapy. 61(6). 27 indexed citations
3.
Yamaguchi, Yuko, et al.. (2016). Sulfonamide-based non-alkyne LpxC inhibitors as Gram-negative antibacterial agents. Bioorganic & Medicinal Chemistry Letters. 27(4). 1045–1049. 26 indexed citations
4.
Yamaguchi, Yûko, et al.. (2016). LpxC Inhibitors: Design, Synthesis, and Biological Evaluation of Oxazolidinones as Gram-negative Antibacterial Agents. ACS Medicinal Chemistry Letters. 7(6). 623–628. 29 indexed citations
5.
Singh, Sheo B., David E. Kaelin, Peter T. Meinke, et al.. (2015). Structure activity relationship of C-2 ether substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-5). Bioorganic & Medicinal Chemistry Letters. 25(17). 3630–3635. 14 indexed citations
6.
Singh, Sheo B., David E. Kaelin, Jin Wu, et al.. (2015). C1–C2-linker substituted 1,5-naphthyridine analogues of oxabicyclooctane-linked NBTIs as broad-spectrum antibacterial agents (part 7). MedChemComm. 6(10). 1773–1780. 8 indexed citations
7.
Singh, Sheo B., Priya Dayananth, Carl J. Balibar, et al.. (2015). Kibdelomycin Is a Bactericidal Broad-Spectrum Aerobic Antibacterial Agent. Antimicrobial Agents and Chemotherapy. 59(6). 3474–3481. 37 indexed citations
8.
Lu, Jun, Sangita B. Patel, Nandini Sharma, et al.. (2014). Structures of Kibdelomycin Bound to Staphylococcus aureus GyrB and ParE Showed a Novel U-Shaped Binding Mode. ACS Chemical Biology. 9(9). 2023–2031. 105 indexed citations
9.
Singh, Sheo B., David E. Kaelin, Jin Wu, et al.. (2014). Oxabicyclooctane-Linked Novel Bacterial Topoisomerase Inhibitors as Broad Spectrum Antibacterial Agents. ACS Medicinal Chemistry Letters. 5(5). 609–614. 58 indexed citations
10.
Yamaguchi, Yuko, Masaya Takei, Ryuta Kishii, Mitsuru Yasuda, & Takashi Deguchi. (2013). Contribution of Topoisomerase IV Mutation to Quinolone Resistance in Mycoplasma genitalium. Antimicrobial Agents and Chemotherapy. 57(4). 1772–1776. 27 indexed citations
11.
Kishii, Ryuta & Masaya Takei. (2009). Relationship between the expression of ompF and quinolone resistance in Escherichia coli. Journal of Infection and Chemotherapy. 15(6). 361–366. 53 indexed citations
12.
Kishii, Ryuta, et al.. (2007). Structural and Functional Studies of the HAMP Domain of EnvZ, an Osmosensing Transmembrane Histidine Kinase in Escherichia coli. Journal of Biological Chemistry. 282(36). 26401–26408. 28 indexed citations
13.
14.
Takei, Masaya, et al.. (2002). Contribution of the C-8-Methoxy Group of Gatifloxacin to Inhibition of Type II Topoisomerases of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 46(10). 3337–3338. 8 indexed citations
15.
Kishii, Ryuta, Masaya Takei, Hideyuki Fukuda, Katsuhiko Hayashi, & M. Hosaka. (2002). Contribution of the 8-Methoxy Group to the Activity of Gatifloxacin against Type II Topoisomerases of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy. 47(1). 77–81. 30 indexed citations
16.
Takei, Masaya, Hideyuki Fukuda, Ryuta Kishii, & M. Hosaka. (2001). Target Preference of 15 Quinolones againstStaphylococcus aureus, Based on Antibacterial Activities and Target Inhibition. Antimicrobial Agents and Chemotherapy. 45(12). 3544–3547. 96 indexed citations
17.
Fukuda, Hideyuki, Ryuta Kishii, Masaya Takei, & M. Hosaka. (2001). Contributions of the 8-Methoxy Group of Gatifloxacin to Resistance Selectivity, Target Preference, and Antibacterial Activity against Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy. 45(6). 1649–1653. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masaya Takei Breakdown of academic impact, for papers by Marina Y. Fosso Breakdown of academic impact, for papers by Hideyuki Fukuda Breakdown of academic impact, for papers by Timothy R. Kane Breakdown of academic impact, for papers by Raymond T. Testa Breakdown of academic impact, for papers by Steven M. Kwasny Breakdown of academic impact, for papers by Martin S. Linsell Breakdown of academic impact, for papers by Takashi Fukuoka Breakdown of academic impact, for papers by Frédéric Collin Breakdown of academic impact, for papers by Srinivas Kodali
Rankless by CCL
2026